Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation

Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation

Introduction: Immune-related adverse events affecting virtually every organ system have been described in individuals receiving immune checkpoint inhibitors. The spectrum of hematologic adverse effects is diverse and includes autoimmune cytopenias, hemolysis, or inhibition of coagulation factors. Th...

Full description

Bibliographic Details
Main Authors: Jacinth J. Joseph, MD, Arun Rajan, MD, James L. Gulley, MD, PhD, Sawa Ito, MD, Craig M. Kessler, MD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:JTO Clinical and Research Reports
Subjects:
Immune checkpoint inhibitors
Immunotherapy
Acquired coagulopathy
Disseminated intravascular coagulation
Inflammatory coagulopathy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300540

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320300540

Similar Items